CI Investments Inc’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-469
Closed -$7K 1329
2025
Q1
$7K Sell
469
-13
-3% -$200 ﹤0.01% 1257
2024
Q4
$7K Sell
482
-441
-48% -$7.19K ﹤0.01% 1260
2024
Q3
$18K Buy
923
+451
+96% +$9.35K ﹤0.01% 1135
2024
Q2
$10K Sell
472
-37
-7% -$735 ﹤0.01% 1167
2024
Q1
$10K Sell
509
-3,427
-87% -$58.8K ﹤0.01% 1208
2023
Q4
$57K Sell
3,936
-4,619
-54% -$62.8K ﹤0.01% 947
2023
Q3
$149K Sell
8,555
-734
-8% -$15.3K ﹤0.01% 728
2023
Q2
$193K Buy
9,289
+2,855
+44% +$62.1K ﹤0.01% 639
2023
Q1
$151K Buy
6,434
+2,196
+52% +$59K ﹤0.01% 650
2022
Q4
$118K Sell
4,238
-633
-13% -$16.2K ﹤0.01% 705
2022
Q3
$114K Sell
4,871
-234
-5% -$7.07K ﹤0.01% 683
2022
Q2
$172K Sell
5,105
-4,580
-47% -$160K ﹤0.01% 632
2022
Q1
$338K Sell
9,685
-1,078
-10% -$36.9K ﹤0.01% 607
2021
Q4
$328K Buy
10,763
+9,655
+871% +$314K ﹤0.01% 671
2021
Q3
$36K Buy
+1,108
New +$35.5K ﹤0.01% 1011

Other funds holding OGN

CI Investments Inc's OGN Position: Q2 2025 in Review

CI Investments Inc sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 469 shares — an estimated $7K sold.

CI Investments Inc first reported a position in OGN in Q3 2021 and held it in 15 quarters. The position peaked at $338K in Q1 2022. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • CI Investments Inc reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • CI Investments Inc sold 469 Organon & Co shares in Q2 2025, an estimated $7K.
  • CI Investments Inc first reported a position in Organon & Co in Q3 2021 and held it in 15 quarters.
  • CI Investments Inc's Organon & Co position peaked at $338K in Q1 2022.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on CI Investments Inc's 13F filing for Q2 2025, filed 12 Aug 2025.